Adult Mouse DRG Explant and Dissociated Cell Models to Investigate Neuroplasticity and Responses to Environmental Insults Including Viral Infection
March 9th, 2018
22.5K views
In this report, the advantages of organotypic cultures and dissociated primary cultures of mouse-derived dorsal root ganglia are highlighted to investigate a wide range of mechanisms associated with neuron-glial interaction, neuroplasticity, neuroinflammation, and response to viral infection.
Overview
This study explores the use of organotypic cultures and dissociated primary cultures from mouse dorsal root ganglia (DRG) to investigate neuron-glial interactions, neuroplasticity, neuroinflammation, and viral infection responses. The methodology allows for the maintenance of organ-like complexity essential for examining cellular responses to environmental cues.
Key Study Components
Area of Science
- Neuroscience
- Cell Culture
- Neurobiology
Background
- Dorsal root ganglia (DRG) play a critical role in sensory processing and pain pathways.
- Understanding how DRG respond to various stimuli can provide insights into neuroplasticity and inflammatory responses.
- Animal models are necessary for studying complex interactions between neurons and glial cells.
Purpose of Study
- To establish an ex vivo model of DRG for studying neuronal responses.
- To elucidate mechanisms behind neuroplasticity and neuroinflammatory responses when exposed to pathogens.
- To improve methodologies for harvesting and culturing DRGs to facilitate research.
Methods Used
- An ex vivo DRG explant model and dissociated cell cultures were employed.
- The method involves careful surgical isolation of DRGs and subsequent culture in serum-free media.
- Cells were treated with collagenase and trypsin to dissociate them for further analysis.
- Timelines and precision in timing are emphasized as critical for cell survival and adherence during culture.
Main Results
- Successful isolation and culture of DRG demonstrate their viability for studying neuronal changes.
- Responses to viral infections in dissociated DRG neurons were measured, indicating changes in cellular interactions.
- Efficient methods were developed for preparing and maintaining DRG, optimizing conditions for research.
Conclusions
- The study establishes reliable techniques for investigating neuronal mechanisms using DRG as a model.
- This work provides insights into neuron-glial interactions and the impact of viral infections on neuronal health.
- Findings have implications for understanding neuroplasticity in health and disease models.
Frequently Asked Questions
What are the advantages of using DRG cultures?
DRG cultures maintain organ-like complexity that is crucial for studying neuronal responses to various treatments and stimuli, offering insights into neuroplasticity and neuroinflammation.
How are DRG harvested and cultured?
DRG are isolated via careful surgical techniques involving the exposure of the vertebral column and extracted with precision to maintain tissue integrity, followed by culture in serum-free media.
What types of cellular responses can be studied with this model?
Researchers can investigate cellular responses to environmental cues, such as neuroplastic changes and responses to viral infections, using this ex vivo model.
How do the methods contribute to understanding neuroinflammation?
The techniques allow for analysis of how DRG respond to pathogenic exposures, providing a clearer picture of the mechanisms underlying neuroinflammation.
What are key considerations when performing the DRG isolation?
Careful timing, surgical precision, and maintaining the DRG's viability are crucial to ensure successful isolation and subsequent culture.
How can this method be adapted or applied in future research?
The established methodologies for DRG handling can be adapted for various investigations in neurobiology, particularly in studies relating to pain mechanisms and neurodegenerative diseases.
Executive Industry Relevance
This ex vivo and in vitro DRG model provides a physiologically relevant system for studying neuronal-glial interactions and neuroplasticity in the peripheral nervous system. It supports mechanistic de-risking in early discovery by enabling controlled investigation of responses to environmental insults, including viral infection, within a native tissue architecture. The model enhances predictive confidence in target validation and pathway modulation studies relevant to neuropathic pain and neuroinflammatory disorders.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to neuron-glial signaling and neuroinflammatory pathways in a disease-relevant system.
- Operational Value: Supports functional target validation by preserving native extracellular microenvironment and cellular crosstalk.
- Predictive Value: Facilitates assessment of target modulation effects on neuroplasticity and neuritogenesis under pathophysiological conditions.
Screening & Assay Development
- Scientific Value: Provides a standardized platform for quantitative assessment of neurite outgrowth, axonal cone dynamics, and glial activation.
- Operational Value: Enables reproducible co-culture systems for screening compounds affecting neuronal metabolism and glial-neuronal communication.
- Scalability: Dissociated DRG-derived cultures allow for multi-well plate formats suitable for assay optimization and reagent testing.
Translational & Preclinical Research
- Scientific Value: Models peripheral nervous system responses to viral pathogens, supporting translational biomarker discovery related to neuroinfection.
- Operational Value: Bridges ex vivo findings with in vitro mechanistic studies to advance understanding of sensory neuron vulnerability.
- Risk Mitigation: Informs preclinical target selection by revealing glial contributions to neuronal pathology following insult.
Pipeline & Workflow Integration
The DRG explant and dissociated cell models integrate into early discovery workflows, supporting hypothesis-driven screening and lead identification efforts focused on peripheral neuropathology and neuroimmune modulation.
- Discovery Biology: Enables mechanistic de-risking of targets involved in neuroplasticity, axonal growth, and glial activation pathways.
- Screening: Supports assay development for quantifying neuritogenesis, glial reactivity, and viral-induced changes in neuronal markers.
- Analytics: Generates quantitative immunofluorescence and co-labeling readouts to assess structural and functional neuronal responses.
- Translational Research: Models PNS-specific pathophysiology relevant to pain and sensory disorders, enabling biomarker-aligned target evaluation.
- Enterprise Reuse: Establishes a reusable platform for iterative testing of compounds across neuroinflammatory and neurodegenerative indications.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in PNS-targeted programs by preserving native neuron-glial architecture and microenvironmental cues.
- Operational Value: Promotes standardization through defined dissociation, plating, and infection protocols that enhance reproducibility across laboratories.
- Strategic Value: Improves go/no-go decision-making by providing early insight into target effects on neuronal resilience and glial-mediated neurotoxicity.
- Portfolio Impact: Enables risk-adjusted prioritization of neurotherapeutic candidates based on human-relevant PNS response data.
Implementation Considerations
- Requires expertise in microsurgical dissection and sterile tissue handling to ensure DRG viability and explant integrity.
- Depends on access to surgical microscopes, precision instruments, and controlled incubation environments for optimal culture outcomes.
- Necessitates standardized timing and reagent protocols (e.g., collagenase/trypsin sequencing) to prevent cell loss or over-digestion during dissociation.
- Requires adaptation of viral titers and MOI based on pathogen-specific infectivity in primary neuronal and glial co-cultures.
- Limited by post-harvest viability window, necessitating timely processing to maintain explant functionality and neuronal health.
Biopharma FAQs
Why is null hypothesis testing important for validating DRG explant models in target validation?
Null hypothesis testing ensures that observed changes in neurite outgrowth or glial activation following treatment are statistically significant and not due to random variability, supporting reliable target engagement conclusions in early discovery.
How does isolating independent variables (e.g., viral load, glial presence) improve target validation in DRG models?
Isolating independent variables allows researchers to attribute specific neuronal responses—such as antiviral marker expression or neurite retraction—to defined experimental conditions, enhancing mechanistic clarity in pathway de-risking.
What quantitative dependent variable measurements enable lead identification in DRG-based assays?
Quantitative readouts such as neurite length, branch points, glial cell coverage, and fluorescence intensity of neuronal or viral markers provide objective metrics to compare compound effects and prioritize leads.
Why are replication requirements critical for cross-functional collaboration in DRG model implementation?
Replication across experiments and laboratories ensures consistent phenotypic responses, enabling confident data sharing between discovery biology, assay development, and preclinical teams for aligned go/no-go decisions.
What statistical analysis capabilities are required before implementing DRG explant models in screening workflows?
Capabilities include normality testing, variance equivalence checks, and appropriate parametric or non-parametric tests (e.g., t-test, ANOVA) to accurately interpret treatment effects on neuronal and glial endpoints.
